Is acetazolamide (carbonic anhydrase inhibitor) safe to use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acetazolamide Use During Pregnancy

Acetazolamide should not be used during pregnancy unless there is imminent risk of vision loss due to idiopathic intracranial hypertension (IIH), as the potential risks to the fetus generally outweigh the benefits. 1

FDA Classification and Safety Profile

Acetazolamide is classified as FDA Pregnancy Category C, indicating:

  • Animal studies have shown adverse effects on the fetus
  • There are no adequate well-controlled studies in pregnant women
  • The drug has been shown to be teratogenic (causing limb defects) in mice, rats, hamsters, and rabbits 2

Clinical Recommendations for IIH Management in Pregnancy

First-Line Approaches (Preferred)

  • Weight management with appropriate gestational weight gain
  • Serial lumbar punctures for temporary relief if vision is threatened
  • Multidisciplinary management involving neurology, ophthalmology, and maternal-fetal medicine 1

Criteria for Considering Acetazolamide

Acetazolamide should only be considered when:

  • IIH is active with imminent risk of vision loss
  • Other measures have failed
  • A thorough risk-benefit discussion has occurred with the patient 1

If deemed necessary:

  • Use the lowest effective dose
  • Limit duration of treatment
  • Obtain detailed informed consent regarding uncertain fetal risks 1

Emerging Evidence on Safety

Despite the FDA classification and manufacturer warnings, some recent research suggests acetazolamide may be safer in human pregnancy than previously thought:

  • A 2013 study of 50 pregnancies with acetazolamide exposure before 13 weeks found no increased risk of spontaneous abortion and no major complications identified in offspring 3
  • Another 2013 publication stated that no evidence has been found regarding adverse effects of acetazolamide use during pregnancy, suggesting it can be taken during pregnancy but with caution and justification 4
  • A 2005 observational case series documented 12 patients with IIH treated with acetazolamide during pregnancy with no adverse pregnancy outcomes 5

Hypertension Management Alternatives in Pregnancy

For management of hypertension in pregnancy, safer alternatives to acetazolamide include:

  • Methyldopa
  • Labetalol
  • Nifedipine 1

Important Monitoring if Acetazolamide is Used

If acetazolamide must be used during pregnancy:

  • Monitor with baseline CBC and platelet count prior to initiating therapy
  • Continue regular monitoring throughout therapy
  • Conduct periodic monitoring of serum electrolytes
  • Discontinue immediately if significant changes occur 2

Key Caution

The American College of Neurology specifically advises against acetazolamide use in pregnant women at 26 weeks of gestation unless there is imminent risk of vision loss due to IIH 1. This recommendation reflects the conservative approach that should be taken when considering this medication during pregnancy.

Human Medical Genetics

AI Assistant: I'll provide a comprehensive answer about acetazolamide use during pregnancy.

Acetazolamide Use During Pregnancy

Acetazolamide should not be used during pregnancy unless there is imminent risk of vision loss due to idiopathic intracranial hypertension (IIH), as the potential risks to the fetus generally outweigh the benefits. 1

FDA Classification and Safety Profile

Acetazolamide is classified as FDA Pregnancy Category C, indicating:

  • Animal studies have shown adverse effects on the fetus
  • There are no adequate well-controlled studies in pregnant women
  • The drug has been shown to be teratogenic (causing limb defects) in mice, rats, hamsters, and rabbits 2

Clinical Recommendations for IIH Management in Pregnancy

First-Line Approaches (Preferred)

  • Weight management with appropriate gestational weight gain
  • Serial lumbar punctures for temporary relief if vision is threatened
  • Multidisciplinary management involving neurology, ophthalmology, and maternal-fetal medicine 1

Criteria for Considering Acetazolamide

Acetazolamide should only be considered when:

  • IIH is active with imminent risk of vision loss
  • Other measures have failed
  • A thorough risk-benefit discussion has occurred with the patient 1

If deemed necessary:

  • Use the lowest effective dose
  • Limit duration of treatment
  • Obtain detailed informed consent regarding uncertain fetal risks 1

Emerging Evidence on Safety

Despite the FDA classification and manufacturer warnings, some recent research suggests acetazolamide may be safer in human pregnancy than previously thought:

  • A 2013 study of 50 pregnancies with acetazolamide exposure before 13 weeks found no increased risk of spontaneous abortion and no major complications identified in offspring 3
  • Another 2013 publication stated that no evidence has been found regarding adverse effects of acetazolamide use during pregnancy, suggesting it can be taken during pregnancy but with caution and justification 4
  • A 2005 observational case series documented 12 patients with IIH treated with acetazolamide during pregnancy with no adverse pregnancy outcomes 5

Hypertension Management Alternatives in Pregnancy

For management of hypertension in pregnancy, safer alternatives to acetazolamide include:

  • Methyldopa
  • Labetalol
  • Nifedipine 1

Important Monitoring if Acetazolamide is Used

If acetazolamide must be used during pregnancy:

  • Monitor with baseline CBC and platelet count prior to initiating therapy
  • Continue regular monitoring throughout therapy
  • Conduct periodic monitoring of serum electrolytes
  • Discontinue immediately if significant changes occur 2

Key Caution

The American College of Neurology specifically advises against acetazolamide use in pregnant women at 26 weeks of gestation unless there is imminent risk of vision loss due to IIH 1. This recommendation reflects the conservative approach that should be taken when considering this medication during pregnancy.

References

Guideline

Management of Idiopathic Intracranial Hypertension in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The use of acetazolamide during pregnancy in intracranial hypertension patients.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2013

Research

Idiopathic intracranial hypertension and pregnancy.

Clinical obstetrics and gynecology, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.